Insulin-resistant lipolysis in abdominally obese hypertensive individuals: Role of the renin-angiotensin system

Hypertension

Volumn 28, Issue 1, 1996, Pages 120-126

  Hennes, Magda M I ^a   O'Shaughnessy, Irene M ^a   Kelly, Thomas M ^a   LaBelle, Patrice ^c   Egan, Brent M ^b   Kissebah, Ahmed H ^a,d  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

Author keywords

calorimetry, indirect; fatty acids; insulin resistance; obesity; renin angiotensin system

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FATTY ACID; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; FEMALE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULINEMIA; LIPID OXIDATION; LIPOLYSIS; MALE; MEAN ARTERIAL PRESSURE; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTEMIC VASCULAR RESISTANCE;

EID: 0030002184     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.1.120     Document Type: Article

References (42)

1. Kissebah AH, Krakower GR. Regional adiposity and mortality. Physiol Rev. 1994;74:761-811.
2. Peiris AN, Sothmann MS, Hoffmann RG, Hennes MMI, Wilson CR, Gustafson AB, Kissebah AH. Adiposity, fat distribution, and cardiovascular risk. Ann Intern Med. 1989;110:867-872.
3. Manicardi V, Camellini L, Bellodi C, Coscelli C, Ferrannini E. Evidence for an association of high blood pressure and hyperinsulinemia in obese man. J Clin Endocrinol Metab. 1986;62:1302-1304.
4. Grugni GA, Ardizzi A, Dubini A, Guzzaloni G, Sartorio A, Morabito F. No correlation between insulin levels and high blood pressure in obese subjects. Horm Metab Res. 1990;22:124-125.
5. Muller DC, Elahi D, Pratley RE, Tobin JD, Andres R. An epidemiological test of the hyperinsulinemia-hypertension hypothesis. J Clin Endocrinol Metab. 1993;76:544-548.
6. O'Shaughnessy IM, Myers TM, Stepniakowski K, Nazzaro P, Kelly TM, Hoffmann RG, Egan BM, Kissebah AH. Glucose metabolism in abdominally obese hypertensive and normotensive subjects. Hypertension. 1995;26:186-192.
7. Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM. Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest. 1989;83:1168-1173.
8. Hennes MMI, Shrago E, Kissebah AH. Receptor and postreceptor effects of free fatty acids (FFA) on hepatocyte insulin dynamics. Int J Obesity. 1990;14:831-841.
9. Svedberg JG, Strömblad G, Wirth A, Smith U, Björntorp P. Fatty acids in the portal vein of the rat regulate hepatic insulin clearance. J Clin Invest. 1991;88:2054-2058.
10. Ferrannini EE, Barrett J, Bevilacqua S, DeFronzo RA. Effect of fatty acids on glucose production and utilization in man. J Clin Invest. 1983;72:1737-1747.
11. Boden G, Chen X, Ruiz J, White JV, Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest. 1994;93: 2438-2446.
12. Kissebah AH, Adams PW, Wynn V. Plasma free fatty acid and triglyceride transport kinetics in man. Clin Sci Mol Med. 1974;47: 259-278.
13. Bulow J, Madsen J, Astrup A, Christensen NJ. Vasoconstrictive effect of high FFA/albumin ratios in adipose tissue in vivo. Acta Physiol Scand. 1985;125:661-667.
14. Bulow J, Madsen J, Hojgaard L. Reversibility of the effects on local circulation of high lipid concentrations in blood. Scand J Clin Lab Invest. 1990;50:291-296.
15. Stepniakowski KT, Egan BM. Additive effects of hypertension and obesity to limit venous distensibility. Am J Physiol. 1995;268:R562-R568.
16. Stepniakowski KT, Goodfriend TL, Egan BM. Fatty acids enhance vascular α-adrenergic sensitivity. Hypertension. 1995;25:774-778.
17. Davda RK, Ullian ME, Stepniakowski KT, Lu G, Goodfriend TL, Egan BM. Oleic acid inhibits endothelial cell nitric oxide synthase by a PKC-independent mechanism. Hypertension. 1995;26:764-770.
18. Lu G, Morinelli TA, Meier KE, Rosenzweig SA, Egan BM. Oleic acid-induced mitogenic signalling in human aortic smooth muscle cells: a role for protein kinase C. J Invest Med. 1995;43:208A. Abstract.
19. Jonsson JR, Game PA, Head RJ, Frewin DB. The expression and localization of the angiotensin-converting enzyme mRNA in human adipose tissue. Blood Pressure. 1994;3:72-75.
20. Frederich RC, Kahn BB, Peach MJ, Flier JS. Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension. 1992;19:339-344.
21. Egan BM, Stepniakowski K, Goodfriend TL. Renin and aldosterone are higher and the hyperinsulinemic effects of salt restriction greater in subjects with risk factor clustering. Am J Hypertens. 1994;7:886-893.
22. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039-1057.
23. Freedman DS, Jacobsen SJ, Barboriak JJ, Sobocinski KA, Andersen AJ, Kissebah AH, Sasse EA, Gruchow SW. Body fat distribution and male/female differences in lipids and lipoproteins. Circulation. 1990;81:1498-1506.
24. Peiris AN, Mueller RA, Smith GA, Struve MF, Kissebah AH. Splanchnic insulin metabolism in obesity: influence of body fat distribution. J Clin Invest. 1986;78:1648-1657.
25. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-E223.
26. Jensen MD, Haymond MW, Gerich JE, Cryer PE, Miles JM. Lipolysis during fasting: decreased suppression by insulin and increased stimulation by epinephrine. J Clin Invest. 1987;87:207-213.
27. Frayn KN. Calculation of oxidation rates in vivo from gaseous exchange. J Appl Physiol. 1983;55:628-634.
28. Neahring JM, Stepniakowski K, Greene AS, Egan BM. Insulin does not reduce forearm α-vasoreactivity in obese hypertensive or lean normotensive men. Hypertension. 1993;22:584-590.
29. Miles JM, Ellman MG, McClean KL, Jensen MD. Validation of a new method for determination of free fatty acid turnover. Am J Physiol. 1987;252:E431-E438.
30. Egan B, Schork N, Weder AB. Regional hemodynamic abnormalities in overweight men: focus on α-adrenergic vascular responses. Am J Hypertens. 1989;2:428-434.
31. Egan B, Panis R, Hinderliter A, Schork N, Julius S. Mechanism of increased alpha-adrenergic vasoconstriction in human essential hypertension. J Clin Invest. 1987;80:812-817.
32. Caspers ML, Bussone M, Dow MJ, Ulanski LJ II, Grammas P. Alterations of cerebromicrovascular Na+, K(+)-ATPase activity due to fatty acids and acute hypertension. Brain Res. 1993;602:215-220.
33. Huang JM, Xian H, Bacaner M. Long-chain fatty acids activate calcium channels in ventricular myocytes. Proc Natl Acad Sci U S A. 1992;89:6452-6456.
34. Khan WA, Blobe G, Halpern A, Taylor W, Wetsel WC, Burns D, Loomis C, Hannun YA. Selective regulation of protein kinase C isoenzymes by oleic acid in human platelets. J Biol Chem. 1993;268: 5063-5068.
35. Roust LR, Jensen MD. Postprandial free fatty acid kinetics are abnormal in upper body obesity. Diabetes. 1993;42:1567-1573.
36. Dzau VJ. Implication of local angiotensin production in cardiovascular physiology and pharmacology. Am J Cardiol. 1987;59A:65A.
37. Ferner RE, Simpson JM, Rawlins MD. Effects of intradermal bradykinin after inhibition of angiotensin converting enzyme. Br Med J. 1987;294:1119-1120.
38. O'Shaughnessy IM, Hennes MM, Egan BM, Kissebah AH. Organ specific regulation of insulin sensitivity by angiotensin converting enzyme inhibition. Abstracts of the 77th Annual Meeting of the Endocrine Society. Washington, DC, 1995.
39. Thiebaud D, DeFronzo RA, Jacot E, Golay A, Acheson K, Maeder E, Jequier E, Felber J-P. Effect of long chain triglyceride infusion on glucose metabolism in man. Metab Clin Exp. 1982;31:1128-1136.
40. Kelly DE, Simoneau J-A. Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest. 1994;94:2349-2356.
41. Colberg SR, Simoneau J-A, Thaete FL, Kelley DE. Skeletal muscle utilization of free fatty acids in women with visceral obesity. J Clin Invest. 1995;95:1846-1853.
42. Groop LC, Bonadonna RC, Shank M, Petrides AS, DeFronzo RA. Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man. J Clin Invest. 1991;87:83-89.